Editor’s Choice: A Childhood Tragedy, New Findings in NAFLD, And the Start of a Clinical Trial

Happy Monday!

This week, we have details on a sad story of a toddler passing away from very rare mesenchymal chondrosarcoma, new research about the genetic risk factors of non-alcoholic fatty liver disease, and the beginning of a new trial for immunological disorders.

source: pixabay.com

After Their Toddler Died of Mesenchymal Chondrosarcoma, Parents Tell Others to Trust Their Instincts

This toddler died very unexpectedly of a rare and almost unknown cancer called mesenchymal chondrosarcoma, but the parents knew that something serious was wrong before the doctors found it. The cancer failed to respond to chemotherapy and surgical treatment.




source: shutterstock.com

Study of the Week: Study Reveals New Genetic Risk Factors for Non-Alcoholic Fatty Liver Disease

A new, large scale study was able to uncover genetic risk factors for non-alcoholic fatty liver disease (NAFLD) that were not understood by previous research.




source: pixabay.com

First Participant Dosed in IMG-004 Trial for Immunological Diseases

Without patient volunteers, groundbreaking research and potential solutions can’t move forward.




Do you have a rare disease experience of your own? Share with us here.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email